Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neuronavigation | 25 | 2024 | 166 | 4.650 |
Why?
|
Brain Neoplasms | 83 | 2024 | 9025 | 4.220 |
Why?
|
Diffusion Tensor Imaging | 33 | 2024 | 2401 | 2.990 |
Why?
|
Neurosurgical Procedures | 28 | 2023 | 2067 | 2.950 |
Why?
|
Brain Mapping | 41 | 2022 | 6635 | 2.930 |
Why?
|
Magnetic Resonance Imaging | 91 | 2024 | 36415 | 2.230 |
Why?
|
Language | 20 | 2024 | 1539 | 2.200 |
Why?
|
Monitoring, Intraoperative | 8 | 2020 | 944 | 1.960 |
Why?
|
Glioma | 25 | 2024 | 3452 | 1.840 |
Why?
|
Neurosurgery | 13 | 2024 | 679 | 1.710 |
Why?
|
Brain | 61 | 2024 | 27094 | 1.580 |
Why?
|
Preoperative Care | 15 | 2024 | 2241 | 1.480 |
Why?
|
Imaging, Three-Dimensional | 25 | 2022 | 4052 | 1.310 |
Why?
|
Surgery, Computer-Assisted | 16 | 2022 | 1003 | 1.220 |
Why?
|
Image Interpretation, Computer-Assisted | 17 | 2020 | 3366 | 1.180 |
Why?
|
Pyramidal Tracts | 6 | 2023 | 251 | 1.080 |
Why?
|
Blood-Brain Barrier | 5 | 2024 | 1028 | 1.050 |
Why?
|
Diffusion Magnetic Resonance Imaging | 13 | 2024 | 2787 | 0.930 |
Why?
|
Microbubbles | 3 | 2024 | 135 | 0.930 |
Why?
|
Image Processing, Computer-Assisted | 31 | 2024 | 8998 | 0.890 |
Why?
|
Functional Laterality | 11 | 2020 | 2257 | 0.870 |
Why?
|
Internal Capsule | 2 | 2014 | 138 | 0.810 |
Why?
|
Epilepsy, Temporal Lobe | 4 | 2009 | 388 | 0.800 |
Why?
|
Hydrocephalus, Normal Pressure | 2 | 2020 | 98 | 0.780 |
Why?
|
Visual Pathways | 5 | 2024 | 550 | 0.770 |
Why?
|
Glioblastoma | 11 | 2024 | 3482 | 0.730 |
Why?
|
Temporal Lobe | 11 | 2021 | 1695 | 0.690 |
Why?
|
Insufflation | 1 | 2020 | 63 | 0.690 |
Why?
|
Software | 10 | 2024 | 4431 | 0.690 |
Why?
|
Spectrum Analysis, Raman | 3 | 2016 | 237 | 0.660 |
Why?
|
Pattern Recognition, Automated | 7 | 2018 | 993 | 0.660 |
Why?
|
Dominance, Cerebral | 3 | 2006 | 623 | 0.640 |
Why?
|
Nerve Fibers, Myelinated | 7 | 2019 | 951 | 0.640 |
Why?
|
Neural Pathways | 14 | 2024 | 3056 | 0.640 |
Why?
|
Memory | 7 | 2017 | 2190 | 0.600 |
Why?
|
Geniculate Bodies | 4 | 2024 | 158 | 0.600 |
Why?
|
Optic Chiasm | 2 | 2021 | 91 | 0.570 |
Why?
|
Craniotomy | 5 | 2023 | 741 | 0.530 |
Why?
|
Intraoperative Period | 5 | 2020 | 510 | 0.530 |
Why?
|
Epilepsy | 9 | 2023 | 3304 | 0.510 |
Why?
|
Auditory Cortex | 1 | 2020 | 364 | 0.510 |
Why?
|
Photic Stimulation | 8 | 2019 | 1984 | 0.510 |
Why?
|
Meningioma | 8 | 2024 | 1216 | 0.490 |
Why?
|
Humans | 182 | 2024 | 761222 | 0.490 |
Why?
|
Ultrasonography | 8 | 2024 | 5969 | 0.490 |
Why?
|
Radiosurgery | 5 | 2018 | 1339 | 0.480 |
Why?
|
Algorithms | 27 | 2024 | 14025 | 0.480 |
Why?
|
Nerve Net | 6 | 2021 | 2288 | 0.470 |
Why?
|
Cerebral Cortex | 6 | 2019 | 5775 | 0.470 |
Why?
|
Trigeminal Nerve | 4 | 2020 | 248 | 0.460 |
Why?
|
Image Enhancement | 13 | 2013 | 2888 | 0.420 |
Why?
|
Angiography, Digital Subtraction | 3 | 2024 | 335 | 0.420 |
Why?
|
Intracranial Aneurysm | 1 | 2022 | 1286 | 0.400 |
Why?
|
Memory Disorders | 2 | 2012 | 1198 | 0.390 |
Why?
|
Neuroanatomy | 1 | 2012 | 71 | 0.380 |
Why?
|
Organic Chemicals | 1 | 2012 | 210 | 0.380 |
Why?
|
Electrodes, Implanted | 4 | 2014 | 839 | 0.370 |
Why?
|
Models, Neurological | 5 | 2018 | 1769 | 0.370 |
Why?
|
Adult | 70 | 2024 | 221120 | 0.370 |
Why?
|
Pattern Recognition, Visual | 4 | 2006 | 824 | 0.370 |
Why?
|
Brain Diseases | 2 | 2013 | 1545 | 0.370 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 4 | 2013 | 265 | 0.370 |
Why?
|
Subtraction Technique | 8 | 2013 | 518 | 0.370 |
Why?
|
Male | 93 | 2024 | 360703 | 0.360 |
Why?
|
Acoustic Stimulation | 1 | 2015 | 1240 | 0.360 |
Why?
|
Electroencephalography | 5 | 2020 | 6242 | 0.360 |
Why?
|
Absorbable Implants | 1 | 2012 | 338 | 0.340 |
Why?
|
Transducers | 2 | 2024 | 244 | 0.340 |
Why?
|
Physical Stimulation | 1 | 2011 | 517 | 0.340 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 2011 | 247 | 0.340 |
Why?
|
Contrast Media | 2 | 2022 | 5311 | 0.330 |
Why?
|
Reproducibility of Results | 24 | 2019 | 20118 | 0.330 |
Why?
|
Head Injuries, Penetrating | 1 | 2009 | 28 | 0.330 |
Why?
|
Meningeal Neoplasms | 6 | 2024 | 1246 | 0.330 |
Why?
|
Polymers | 2 | 2016 | 1617 | 0.320 |
Why?
|
Wood | 1 | 2009 | 92 | 0.320 |
Why?
|
Eye Foreign Bodies | 1 | 2009 | 51 | 0.320 |
Why?
|
Hand | 2 | 2014 | 902 | 0.320 |
Why?
|
Laser Therapy | 1 | 2015 | 1094 | 0.310 |
Why?
|
Female | 86 | 2024 | 392552 | 0.310 |
Why?
|
Young Adult | 32 | 2024 | 59222 | 0.310 |
Why?
|
Middle Aged | 60 | 2024 | 220858 | 0.310 |
Why?
|
Echoencephalography | 1 | 2009 | 134 | 0.310 |
Why?
|
Fingers | 1 | 2011 | 506 | 0.300 |
Why?
|
Orbital Fractures | 1 | 2009 | 109 | 0.300 |
Why?
|
Seizures | 7 | 2024 | 2965 | 0.300 |
Why?
|
Evoked Potentials, Motor | 1 | 2011 | 464 | 0.300 |
Why?
|
Neoplasm, Residual | 4 | 2020 | 1008 | 0.290 |
Why?
|
Semantics | 2 | 2022 | 612 | 0.290 |
Why?
|
Retinal Detachment | 1 | 2012 | 429 | 0.290 |
Why?
|
Pituitary Neoplasms | 5 | 2024 | 1322 | 0.280 |
Why?
|
Glutarates | 2 | 2022 | 243 | 0.280 |
Why?
|
Ventriculoperitoneal Shunt | 2 | 2020 | 187 | 0.280 |
Why?
|
Sensitivity and Specificity | 18 | 2015 | 14675 | 0.280 |
Why?
|
Hippocampus | 2 | 2012 | 3754 | 0.280 |
Why?
|
Trigeminal Neuralgia | 3 | 2015 | 107 | 0.270 |
Why?
|
Antineoplastic Agents, Alkylating | 2 | 2024 | 617 | 0.270 |
Why?
|
Speech | 3 | 2009 | 554 | 0.270 |
Why?
|
Mathematical Computing | 1 | 2006 | 142 | 0.270 |
Why?
|
Verbal Learning | 2 | 2006 | 463 | 0.270 |
Why?
|
Salvage Therapy | 4 | 2018 | 1264 | 0.260 |
Why?
|
Orbit | 1 | 2009 | 457 | 0.260 |
Why?
|
Mental Processes | 1 | 2007 | 244 | 0.260 |
Why?
|
Therapy, Computer-Assisted | 1 | 2007 | 265 | 0.250 |
Why?
|
Retrospective Studies | 27 | 2024 | 80675 | 0.250 |
Why?
|
Principal Component Analysis | 1 | 2008 | 942 | 0.240 |
Why?
|
Neuroendoscopy | 2 | 2016 | 99 | 0.240 |
Why?
|
Vision Disorders | 1 | 2012 | 1089 | 0.230 |
Why?
|
Isocitrate Dehydrogenase | 3 | 2022 | 937 | 0.230 |
Why?
|
Brain Edema | 3 | 2020 | 604 | 0.230 |
Why?
|
Atlases as Topic | 2 | 2016 | 247 | 0.230 |
Why?
|
Computer Simulation | 8 | 2024 | 6224 | 0.230 |
Why?
|
Artifacts | 5 | 2022 | 1912 | 0.230 |
Why?
|
Holography | 1 | 2024 | 80 | 0.220 |
Why?
|
Psychomotor Performance | 4 | 2019 | 1880 | 0.220 |
Why?
|
Oligodendroglioma | 4 | 2015 | 278 | 0.220 |
Why?
|
Aged | 35 | 2024 | 169292 | 0.210 |
Why?
|
Anisotropy | 3 | 2019 | 1284 | 0.210 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2012 | 1549 | 0.210 |
Why?
|
Emotions | 3 | 2020 | 2742 | 0.210 |
Why?
|
Hyperostosis | 1 | 2022 | 29 | 0.210 |
Why?
|
Forecasting | 4 | 2020 | 2928 | 0.210 |
Why?
|
Sonication | 2 | 2020 | 79 | 0.210 |
Why?
|
Acoustics | 1 | 2024 | 243 | 0.210 |
Why?
|
Survivors | 2 | 2014 | 2369 | 0.210 |
Why?
|
Tomography, Optical Coherence | 1 | 2016 | 2923 | 0.210 |
Why?
|
Skull Base | 2 | 2019 | 292 | 0.200 |
Why?
|
Edema | 2 | 2017 | 764 | 0.200 |
Why?
|
Pupil | 1 | 2023 | 145 | 0.200 |
Why?
|
Finite Element Analysis | 3 | 2021 | 437 | 0.190 |
Why?
|
Race Relations | 1 | 2001 | 37 | 0.190 |
Why?
|
Association | 1 | 2021 | 52 | 0.190 |
Why?
|
Psycholinguistics | 1 | 2021 | 79 | 0.190 |
Why?
|
Electric Stimulation | 5 | 2022 | 1736 | 0.190 |
Why?
|
Visual Perception | 4 | 2019 | 1386 | 0.190 |
Why?
|
Drug Delivery Systems | 2 | 2024 | 2223 | 0.180 |
Why?
|
Pulmonary Edema | 1 | 2023 | 408 | 0.180 |
Why?
|
Ultrasonography, Interventional | 1 | 2009 | 1496 | 0.180 |
Why?
|
Language Tests | 3 | 2009 | 190 | 0.180 |
Why?
|
Essential Tremor | 1 | 2022 | 157 | 0.170 |
Why?
|
Theory of Mind | 1 | 2021 | 92 | 0.170 |
Why?
|
Feasibility Studies | 3 | 2024 | 5250 | 0.170 |
Why?
|
Topoisomerase I Inhibitors | 1 | 2020 | 70 | 0.170 |
Why?
|
Neoplasms | 4 | 2023 | 22142 | 0.170 |
Why?
|
Dissection | 1 | 2021 | 297 | 0.170 |
Why?
|
Nitriles | 1 | 2024 | 971 | 0.160 |
Why?
|
Freedom | 1 | 2019 | 69 | 0.160 |
Why?
|
Phantoms, Imaging | 3 | 2024 | 2513 | 0.160 |
Why?
|
Pyridones | 1 | 2024 | 809 | 0.160 |
Why?
|
Prolactinoma | 1 | 2020 | 113 | 0.160 |
Why?
|
Multilingualism | 1 | 2020 | 87 | 0.160 |
Why?
|
Deep Brain Stimulation | 1 | 2007 | 829 | 0.160 |
Why?
|
Neurilemmoma | 1 | 2024 | 523 | 0.160 |
Why?
|
Stereotaxic Techniques | 3 | 2020 | 555 | 0.160 |
Why?
|
Cranial Nerves | 2 | 2016 | 98 | 0.150 |
Why?
|
Diagnostic Imaging | 5 | 2016 | 3534 | 0.150 |
Why?
|
Artificial Intelligence | 5 | 2011 | 2576 | 0.150 |
Why?
|
Association Learning | 1 | 2019 | 221 | 0.150 |
Why?
|
Intracranial Pressure | 1 | 2020 | 324 | 0.150 |
Why?
|
Head | 2 | 2021 | 922 | 0.150 |
Why?
|
Equipment Failure Analysis | 2 | 2011 | 846 | 0.140 |
Why?
|
Optic Nerve | 1 | 2021 | 571 | 0.140 |
Why?
|
Supratentorial Neoplasms | 2 | 2010 | 159 | 0.140 |
Why?
|
Adenoma | 2 | 2019 | 2159 | 0.140 |
Why?
|
Visual Cortex | 3 | 2015 | 1104 | 0.140 |
Why?
|
Infarction | 1 | 1998 | 248 | 0.140 |
Why?
|
Intraoperative Care | 5 | 2014 | 767 | 0.140 |
Why?
|
Amobarbital | 2 | 2009 | 43 | 0.140 |
Why?
|
Cerebral Revascularization | 1 | 1999 | 259 | 0.130 |
Why?
|
Reaction Time | 2 | 2010 | 2087 | 0.130 |
Why?
|
Carboplatin | 1 | 2019 | 793 | 0.130 |
Why?
|
Neoplasms, Neuroepithelial | 1 | 2016 | 42 | 0.130 |
Why?
|
Robotics | 3 | 2013 | 817 | 0.130 |
Why?
|
Models, Anatomic | 3 | 2019 | 683 | 0.130 |
Why?
|
Moyamoya Disease | 1 | 1999 | 265 | 0.130 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2022 | 4574 | 0.130 |
Why?
|
Hemifacial Spasm | 1 | 2015 | 24 | 0.130 |
Why?
|
Arachnoid Cysts | 1 | 2016 | 60 | 0.130 |
Why?
|
Patient Care Planning | 2 | 2011 | 901 | 0.130 |
Why?
|
Dermoid Cyst | 1 | 2016 | 92 | 0.130 |
Why?
|
Equipment Design | 4 | 2015 | 3510 | 0.120 |
Why?
|
Electric Stimulation Therapy | 1 | 2021 | 625 | 0.120 |
Why?
|
Data Interpretation, Statistical | 4 | 2014 | 2691 | 0.120 |
Why?
|
Magnetoencephalography | 3 | 2011 | 636 | 0.120 |
Why?
|
Nerve Fibers | 2 | 2017 | 707 | 0.120 |
Why?
|
Social Behavior | 1 | 2001 | 1136 | 0.120 |
Why?
|
Elasticity Imaging Techniques | 1 | 2019 | 389 | 0.120 |
Why?
|
REM Sleep Behavior Disorder | 1 | 2015 | 108 | 0.120 |
Why?
|
Pons | 1 | 2015 | 240 | 0.120 |
Why?
|
Anatomy, Artistic | 1 | 2014 | 51 | 0.120 |
Why?
|
Retina | 2 | 2024 | 2656 | 0.110 |
Why?
|
Medical Oncology | 2 | 2021 | 2320 | 0.110 |
Why?
|
Lateral Ventricles | 1 | 2015 | 145 | 0.110 |
Why?
|
Dissociative Disorders | 1 | 2016 | 234 | 0.110 |
Why?
|
Frontal Lobe | 3 | 2019 | 1416 | 0.110 |
Why?
|
Ventriculostomy | 1 | 2015 | 131 | 0.110 |
Why?
|
Brain Injuries | 1 | 2005 | 2054 | 0.110 |
Why?
|
Hallucinations | 1 | 2015 | 366 | 0.100 |
Why?
|
Intracranial Embolism and Thrombosis | 1 | 1992 | 144 | 0.100 |
Why?
|
Rest | 2 | 2020 | 920 | 0.100 |
Why?
|
Dielectric Spectroscopy | 1 | 2012 | 27 | 0.100 |
Why?
|
Evoked Potentials, Visual | 2 | 2012 | 417 | 0.100 |
Why?
|
Histocytochemistry | 1 | 2013 | 697 | 0.100 |
Why?
|
Pilot Projects | 5 | 2024 | 8642 | 0.100 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2016 | 890 | 0.100 |
Why?
|
Astrocytoma | 3 | 2013 | 774 | 0.100 |
Why?
|
Dacarbazine | 1 | 2015 | 559 | 0.100 |
Why?
|
Neurologic Examination | 1 | 2015 | 915 | 0.100 |
Why?
|
Positron-Emission Tomography | 5 | 2013 | 6586 | 0.100 |
Why?
|
Neuropsychological Tests | 3 | 2010 | 7046 | 0.100 |
Why?
|
Aphasia | 1 | 2013 | 192 | 0.100 |
Why?
|
Catheters | 1 | 2015 | 426 | 0.100 |
Why?
|
Aged, 80 and over | 13 | 2019 | 58952 | 0.100 |
Why?
|
User-Computer Interface | 3 | 2015 | 1393 | 0.100 |
Why?
|
Coma | 1 | 1995 | 484 | 0.090 |
Why?
|
Malformations of Cortical Development | 1 | 2013 | 176 | 0.090 |
Why?
|
Postoperative Complications | 7 | 2019 | 15637 | 0.090 |
Why?
|
Tumor Burden | 2 | 2018 | 1892 | 0.090 |
Why?
|
Databases, Factual | 2 | 2024 | 7965 | 0.090 |
Why?
|
Adolescent | 14 | 2019 | 88300 | 0.090 |
Why?
|
Prefrontal Cortex | 1 | 2001 | 2219 | 0.090 |
Why?
|
Brain Waves | 2 | 2012 | 409 | 0.090 |
Why?
|
Anticonvulsants | 3 | 2024 | 1910 | 0.090 |
Why?
|
Occipital Lobe | 1 | 2012 | 374 | 0.090 |
Why?
|
Sphenoid Sinus | 1 | 2011 | 99 | 0.090 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2015 | 610 | 0.090 |
Why?
|
Sella Turcica | 1 | 2011 | 117 | 0.090 |
Why?
|
Telomerase | 1 | 2015 | 741 | 0.090 |
Why?
|
Treatment Outcome | 12 | 2024 | 64681 | 0.090 |
Why?
|
Cranial Fossa, Middle | 1 | 2009 | 29 | 0.080 |
Why?
|
Mass Spectrometry | 2 | 2014 | 2189 | 0.080 |
Why?
|
Computer-Assisted Instruction | 1 | 2013 | 362 | 0.080 |
Why?
|
Central Nervous System Vascular Malformations | 1 | 2011 | 140 | 0.080 |
Why?
|
Parietal Lobe | 3 | 2021 | 852 | 0.080 |
Why?
|
Echo-Planar Imaging | 2 | 2018 | 663 | 0.080 |
Why?
|
Organ Size | 2 | 2015 | 2253 | 0.080 |
Why?
|
Transcranial Magnetic Stimulation | 2 | 2011 | 1473 | 0.080 |
Why?
|
Biopsy, Needle | 1 | 2014 | 1624 | 0.080 |
Why?
|
Evoked Potentials | 1 | 2015 | 1047 | 0.080 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2014 | 1784 | 0.080 |
Why?
|
Vitrectomy | 1 | 2012 | 391 | 0.080 |
Why?
|
Brain Abscess | 1 | 2009 | 120 | 0.080 |
Why?
|
Cancer Vaccines | 1 | 2016 | 1038 | 0.080 |
Why?
|
Microscopy | 1 | 2013 | 904 | 0.080 |
Why?
|
Hydrocephalus | 1 | 2015 | 764 | 0.080 |
Why?
|
Optic Nerve Injuries | 1 | 2009 | 150 | 0.080 |
Why?
|
Therapeutic Irrigation | 1 | 2009 | 293 | 0.080 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 1992 | 513 | 0.070 |
Why?
|
Oxygen | 4 | 2017 | 4228 | 0.070 |
Why?
|
Biological Clocks | 1 | 2010 | 318 | 0.070 |
Why?
|
Computer Communication Networks | 1 | 2009 | 295 | 0.070 |
Why?
|
History, 21st Century | 2 | 2011 | 1567 | 0.070 |
Why?
|
Skull | 2 | 2022 | 818 | 0.070 |
Why?
|
Neoplasms, Second Primary | 1 | 2015 | 1052 | 0.070 |
Why?
|
Radiology Department, Hospital | 1 | 2011 | 407 | 0.070 |
Why?
|
Animals | 11 | 2024 | 168089 | 0.070 |
Why?
|
Antineoplastic Agents | 2 | 2020 | 13632 | 0.070 |
Why?
|
Molecular Imaging | 1 | 2013 | 818 | 0.070 |
Why?
|
Longevity | 1 | 2014 | 1063 | 0.070 |
Why?
|
Phospholipids | 1 | 2010 | 784 | 0.070 |
Why?
|
Survival Rate | 3 | 2015 | 12728 | 0.070 |
Why?
|
Music | 1 | 2009 | 245 | 0.070 |
Why?
|
Anterior Temporal Lobectomy | 1 | 2006 | 46 | 0.070 |
Why?
|
DNA Copy Number Variations | 1 | 2015 | 2024 | 0.070 |
Why?
|
Thromboembolism | 1 | 1992 | 992 | 0.070 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2008 | 187 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2022 | 9278 | 0.070 |
Why?
|
Point-of-Care Systems | 1 | 2015 | 1212 | 0.060 |
Why?
|
History, 20th Century | 2 | 2011 | 2765 | 0.060 |
Why?
|
Voice | 1 | 2009 | 268 | 0.060 |
Why?
|
Alcoholism | 1 | 2016 | 1973 | 0.060 |
Why?
|
Blindness | 1 | 2009 | 586 | 0.060 |
Why?
|
Age Factors | 4 | 2015 | 18384 | 0.060 |
Why?
|
Heparin | 1 | 1992 | 1632 | 0.060 |
Why?
|
Information Storage and Retrieval | 1 | 2011 | 820 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 5 | 2019 | 20588 | 0.060 |
Why?
|
Brain Ischemia | 2 | 2015 | 3032 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2023 | 5333 | 0.060 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2009 | 1490 | 0.060 |
Why?
|
Cerebral Hemorrhage | 1 | 2016 | 2642 | 0.060 |
Why?
|
Decompression, Surgical | 1 | 2009 | 607 | 0.060 |
Why?
|
Heart Valve Prosthesis | 1 | 1992 | 1463 | 0.060 |
Why?
|
Consultants | 1 | 2024 | 56 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2022 | 5666 | 0.060 |
Why?
|
Sex Factors | 2 | 2015 | 10553 | 0.060 |
Why?
|
Cluster Analysis | 2 | 2010 | 2706 | 0.060 |
Why?
|
Phenotype | 1 | 2021 | 16575 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2005 | 8606 | 0.050 |
Why?
|
Intraocular Pressure | 1 | 2009 | 1294 | 0.050 |
Why?
|
Professional Competence | 1 | 2006 | 430 | 0.050 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2016 | 4373 | 0.050 |
Why?
|
Reference Values | 2 | 2011 | 4921 | 0.050 |
Why?
|
Guidelines as Topic | 1 | 2009 | 1385 | 0.050 |
Why?
|
Receptors, AMPA | 1 | 2024 | 335 | 0.050 |
Why?
|
Observer Variation | 3 | 2018 | 2610 | 0.050 |
Why?
|
Review Literature as Topic | 1 | 2005 | 348 | 0.050 |
Why?
|
Probability | 1 | 2008 | 2478 | 0.050 |
Why?
|
Pandemics | 1 | 2023 | 8663 | 0.050 |
Why?
|
Injections, Intra-Arterial | 1 | 2002 | 181 | 0.050 |
Why?
|
Neurons | 2 | 2019 | 9429 | 0.050 |
Why?
|
Angiography | 1 | 2008 | 1597 | 0.050 |
Why?
|
Motor Activity | 2 | 2024 | 2712 | 0.050 |
Why?
|
Biomedical Research | 1 | 2017 | 3434 | 0.050 |
Why?
|
Progestins | 1 | 2024 | 301 | 0.050 |
Why?
|
Photography | 1 | 2005 | 532 | 0.050 |
Why?
|
Time Factors | 5 | 2017 | 39957 | 0.050 |
Why?
|
Rats | 4 | 2024 | 23705 | 0.050 |
Why?
|
Cognition | 2 | 2011 | 6988 | 0.050 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2022 | 410 | 0.050 |
Why?
|
Gene Expression Profiling | 2 | 2015 | 9417 | 0.050 |
Why?
|
Predictive Value of Tests | 2 | 2015 | 15308 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 2 | 2024 | 8164 | 0.050 |
Why?
|
Developing Countries | 2 | 2024 | 2863 | 0.050 |
Why?
|
Glasgow Coma Scale | 1 | 2023 | 580 | 0.050 |
Why?
|
Gene Expression | 1 | 2014 | 7571 | 0.050 |
Why?
|
Quality of Life | 1 | 2023 | 13367 | 0.050 |
Why?
|
Neoplasm Transplantation | 2 | 2016 | 2010 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2009 | 6223 | 0.050 |
Why?
|
Endoscopy | 1 | 2011 | 1852 | 0.050 |
Why?
|
Motor Cortex | 1 | 2008 | 1006 | 0.040 |
Why?
|
Lipids | 1 | 2011 | 3331 | 0.040 |
Why?
|
Thorax | 1 | 2023 | 555 | 0.040 |
Why?
|
Surgical Wound Infection | 1 | 2009 | 1530 | 0.040 |
Why?
|
Regression Analysis | 2 | 2010 | 6345 | 0.040 |
Why?
|
Purpura | 1 | 2020 | 117 | 0.040 |
Why?
|
Behavior | 1 | 2002 | 540 | 0.040 |
Why?
|
Rats, Inbred F344 | 1 | 2020 | 826 | 0.040 |
Why?
|
Brazil | 1 | 2023 | 1228 | 0.040 |
Why?
|
Electromagnetic Phenomena | 2 | 2015 | 160 | 0.040 |
Why?
|
Rhizotomy | 1 | 1998 | 30 | 0.040 |
Why?
|
Steroids | 1 | 2024 | 929 | 0.040 |
Why?
|
Follow-Up Studies | 6 | 2018 | 39127 | 0.040 |
Why?
|
Propensity Score | 2 | 2017 | 1916 | 0.040 |
Why?
|
Problem Solving | 1 | 2021 | 443 | 0.040 |
Why?
|
Prodrugs | 1 | 2020 | 262 | 0.040 |
Why?
|
Prognosis | 5 | 2023 | 29688 | 0.040 |
Why?
|
Neoplasm Metastasis | 2 | 2019 | 4909 | 0.040 |
Why?
|
Carotid Arteries | 1 | 2002 | 941 | 0.040 |
Why?
|
Normal Distribution | 1 | 2018 | 272 | 0.040 |
Why?
|
Carbamazepine | 1 | 1998 | 224 | 0.040 |
Why?
|
Meninges | 1 | 1999 | 197 | 0.040 |
Why?
|
Perioperative Period | 1 | 2019 | 252 | 0.040 |
Why?
|
Carotid Stenosis | 2 | 1995 | 859 | 0.040 |
Why?
|
Retreatment | 1 | 1998 | 598 | 0.030 |
Why?
|
4-1BB Ligand | 1 | 2016 | 29 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2008 | 3571 | 0.030 |
Why?
|
Depersonalization | 1 | 2016 | 39 | 0.030 |
Why?
|
Growth Hormone-Secreting Pituitary Adenoma | 1 | 2016 | 49 | 0.030 |
Why?
|
OX40 Ligand | 1 | 2016 | 57 | 0.030 |
Why?
|
Hormones | 1 | 2020 | 868 | 0.030 |
Why?
|
Child | 7 | 2019 | 80154 | 0.030 |
Why?
|
Neuroma, Acoustic | 1 | 1999 | 458 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 15920 | 0.030 |
Why?
|
Utah | 2 | 2006 | 130 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 1999 | 1498 | 0.030 |
Why?
|
ACTH-Secreting Pituitary Adenoma | 1 | 2016 | 63 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 1999 | 982 | 0.030 |
Why?
|
Random Allocation | 1 | 2020 | 2393 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2015 | 12676 | 0.030 |
Why?
|
Syndrome | 1 | 2022 | 3271 | 0.030 |
Why?
|
Blood Flow Velocity | 1 | 1999 | 1375 | 0.030 |
Why?
|
Postoperative Period | 1 | 2020 | 1818 | 0.030 |
Why?
|
Karnofsky Performance Status | 1 | 2015 | 166 | 0.030 |
Why?
|
Face | 1 | 2001 | 1025 | 0.030 |
Why?
|
Hospitalization | 1 | 2015 | 10707 | 0.030 |
Why?
|
Analgesics, Non-Narcotic | 1 | 1998 | 370 | 0.030 |
Why?
|
Biological Transport | 1 | 2019 | 2081 | 0.030 |
Why?
|
Remission, Spontaneous | 1 | 1995 | 384 | 0.030 |
Why?
|
Frozen Sections | 1 | 2015 | 153 | 0.030 |
Why?
|
Disease Progression | 4 | 2017 | 13511 | 0.030 |
Why?
|
Combined Modality Therapy | 2 | 2018 | 8519 | 0.030 |
Why?
|
Ultrasonography, Doppler, Duplex | 1 | 1995 | 198 | 0.030 |
Why?
|
Cadaver | 1 | 2019 | 1358 | 0.030 |
Why?
|
Tissue Fixation | 1 | 2015 | 241 | 0.030 |
Why?
|
Arteries | 1 | 1999 | 1121 | 0.030 |
Why?
|
K562 Cells | 1 | 2016 | 640 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2022 | 3155 | 0.030 |
Why?
|
Ultrasonography, Doppler | 1 | 2016 | 462 | 0.030 |
Why?
|
Hematoxylin | 1 | 2013 | 60 | 0.030 |
Why?
|
Eosine Yellowish-(YS) | 1 | 2013 | 69 | 0.030 |
Why?
|
Pituitary ACTH Hypersecretion | 1 | 2016 | 179 | 0.030 |
Why?
|
Fiducial Markers | 1 | 2015 | 132 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2015 | 473 | 0.030 |
Why?
|
Prospective Studies | 6 | 2023 | 54437 | 0.030 |
Why?
|
Hearing Loss, Sensorineural | 1 | 1999 | 781 | 0.030 |
Why?
|
Radiography | 2 | 2014 | 6974 | 0.030 |
Why?
|
Selection Bias | 1 | 2015 | 359 | 0.030 |
Why?
|
Diagnosis, Differential | 3 | 2013 | 12976 | 0.030 |
Why?
|
Plasmalogens | 1 | 2013 | 30 | 0.030 |
Why?
|
Elasticity | 2 | 2005 | 655 | 0.030 |
Why?
|
Wakefulness | 1 | 2020 | 1264 | 0.030 |
Why?
|
Health Personnel | 1 | 2006 | 3337 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2022 | 16954 | 0.030 |
Why?
|
Thyrotropin | 1 | 2016 | 833 | 0.030 |
Why?
|
Cranial Irradiation | 1 | 2015 | 390 | 0.030 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 26072 | 0.030 |
Why?
|
Mice | 5 | 2022 | 81330 | 0.030 |
Why?
|
Color | 1 | 2013 | 297 | 0.030 |
Why?
|
Calibration | 1 | 2015 | 819 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2019 | 1432 | 0.020 |
Why?
|
Lymphocyte Activation | 2 | 2016 | 5478 | 0.020 |
Why?
|
Phosphatidylinositols | 1 | 2013 | 281 | 0.020 |
Why?
|
Prostheses and Implants | 1 | 2019 | 1273 | 0.020 |
Why?
|
Models, Biological | 2 | 2005 | 9458 | 0.020 |
Why?
|
Reference Standards | 1 | 2015 | 1005 | 0.020 |
Why?
|
Survival Analysis | 2 | 2015 | 10088 | 0.020 |
Why?
|
Phosphatidylserines | 1 | 2013 | 185 | 0.020 |
Why?
|
Recurrence | 3 | 2012 | 8457 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2023 | 26200 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2017 | 12474 | 0.020 |
Why?
|
Cerebrovascular Circulation | 1 | 2001 | 2725 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2008 | 6341 | 0.020 |
Why?
|
Biopsy | 2 | 2013 | 6781 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2016 | 2112 | 0.020 |
Why?
|
Child, Preschool | 3 | 2019 | 42225 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2009 | 7407 | 0.020 |
Why?
|
Cerebral Angiography | 1 | 2016 | 1281 | 0.020 |
Why?
|
Eye Movements | 1 | 2014 | 510 | 0.020 |
Why?
|
Blood Vessels | 1 | 2016 | 1111 | 0.020 |
Why?
|
Mutation | 1 | 2015 | 30004 | 0.020 |
Why?
|
Stroke | 2 | 2015 | 9721 | 0.020 |
Why?
|
Models, Animal | 1 | 2016 | 2114 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5869 | 0.020 |
Why?
|
Electrodes | 1 | 2011 | 611 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2023 | 5295 | 0.020 |
Why?
|
PTEN Phosphohydrolase | 1 | 2015 | 1111 | 0.020 |
Why?
|
Personnel, Hospital | 1 | 2011 | 285 | 0.020 |
Why?
|
Polysomnography | 1 | 2015 | 1848 | 0.020 |
Why?
|
Ischemic Attack, Transient | 1 | 1994 | 874 | 0.020 |
Why?
|
Goals | 1 | 2014 | 710 | 0.020 |
Why?
|
Markov Chains | 1 | 2011 | 965 | 0.020 |
Why?
|
Education | 1 | 2011 | 536 | 0.020 |
Why?
|
Echocardiography, Transesophageal | 1 | 1994 | 1086 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 1132 | 0.020 |
Why?
|
Collagen | 1 | 2016 | 2635 | 0.020 |
Why?
|
Models, Statistical | 2 | 2013 | 5081 | 0.020 |
Why?
|
Cerebrovascular Disorders | 1 | 1994 | 1474 | 0.020 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 1989 | 897 | 0.020 |
Why?
|
Uncertainty | 1 | 2011 | 752 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2015 | 6067 | 0.020 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2011 | 710 | 0.020 |
Why?
|
Neoplasm Staging | 2 | 2010 | 11119 | 0.020 |
Why?
|
Internet | 1 | 2017 | 3096 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2013 | 2329 | 0.010 |
Why?
|
Lung | 1 | 2023 | 9979 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2015 | 2915 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6819 | 0.010 |
Why?
|
Auditory Perception | 1 | 2009 | 584 | 0.010 |
Why?
|
Medical Records | 1 | 2010 | 1409 | 0.010 |
Why?
|
Nanoparticles | 1 | 2016 | 1959 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2015 | 5773 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2010 | 2359 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 3418 | 0.010 |
Why?
|
Vaccination | 1 | 2016 | 3369 | 0.010 |
Why?
|
Coronary Angiography | 1 | 1995 | 4507 | 0.010 |
Why?
|
Attention | 1 | 2014 | 2394 | 0.010 |
Why?
|
Epitopes | 1 | 1989 | 2504 | 0.010 |
Why?
|
Motion | 1 | 2005 | 779 | 0.010 |
Why?
|
Specialization | 1 | 2007 | 778 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11067 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12052 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2014 | 4404 | 0.010 |
Why?
|
Genotype | 1 | 2015 | 12985 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 1989 | 2549 | 0.010 |
Why?
|
Facial Nerve Injuries | 1 | 1999 | 64 | 0.010 |
Why?
|
Audiometry | 1 | 1999 | 253 | 0.010 |
Why?
|
Societies, Medical | 1 | 2011 | 3923 | 0.010 |
Why?
|
Patient Selection | 1 | 2010 | 4246 | 0.010 |
Why?
|
Movement | 1 | 2004 | 1476 | 0.010 |
Why?
|
Odds Ratio | 1 | 2010 | 9652 | 0.010 |
Why?
|
Incidence | 1 | 2015 | 21366 | 0.010 |
Why?
|
Internship and Residency | 1 | 2015 | 5885 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2011 | 14610 | 0.010 |
Why?
|
Infant | 1 | 2015 | 36170 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 1989 | 9187 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2010 | 15841 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 1989 | 10203 | 0.010 |
Why?
|
Coronary Aneurysm | 1 | 1994 | 233 | 0.010 |
Why?
|
Cohort Studies | 1 | 2014 | 41496 | 0.010 |
Why?
|
Risk Factors | 2 | 2015 | 74241 | 0.010 |
Why?
|
Pregnancy | 1 | 1992 | 29893 | 0.010 |
Why?
|
United States | 2 | 2009 | 72341 | 0.010 |
Why?
|
Mice, Inbred AKR | 1 | 1989 | 104 | 0.010 |
Why?
|
Binding Sites, Antibody | 1 | 1989 | 338 | 0.000 |
Why?
|
Research Design | 1 | 2004 | 6180 | 0.000 |
Why?
|
Mice, Inbred CBA | 1 | 1989 | 438 | 0.000 |
Why?
|
Precipitin Tests | 1 | 1989 | 812 | 0.000 |
Why?
|
Mice, Inbred DBA | 1 | 1989 | 623 | 0.000 |
Why?
|
Mice, Inbred C3H | 1 | 1989 | 914 | 0.000 |
Why?
|
Binding, Competitive | 1 | 1989 | 1140 | 0.000 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 1989 | 445 | 0.000 |
Why?
|
Rats, Inbred Lew | 1 | 1989 | 1159 | 0.000 |
Why?
|
Clone Cells | 1 | 1989 | 1668 | 0.000 |
Why?
|
Antigen-Presenting Cells | 1 | 1989 | 965 | 0.000 |
Why?
|
Cricetinae | 1 | 1989 | 2412 | 0.000 |
Why?
|
Species Specificity | 1 | 1989 | 2406 | 0.000 |
Why?
|
Mice, Inbred BALB C | 1 | 1989 | 6200 | 0.000 |
Why?
|
Cell Line | 1 | 1989 | 15545 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 1989 | 22128 | 0.000 |
Why?
|